Literature DB >> 19900650

Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke.

Laura J Gray1, Myzoon Ali, Patrick D Lyden, Philip M W Bath.   

Abstract

INTRODUCTION: The National Institutes of Health Stroke Scale (NIHSS) and Scandinavian Stroke Scale (SSS) are both validated measures of neurologic impairment and have been used in many acute stroke trials. Methods for interconverting SSS and NIHSS are needed.
METHODS: Conversion equations were developed using linear regression (both unadjusted, and adjusted for age and sex) using a random 50% of the data at both baseline and 90 days. The remaining 50% of data were used to test the accuracy of the models produced.
RESULTS: Data from 5 acute stroke trials (2004 patients) were included. Fitted models at baseline were NIHSS = 25.68 - 0.43 * SSS (R(2) = 0.57, prediction error [PE] -0.2, P = .20), and SSS = 50.37 - 1.63 * NIHSS (R(2) = 0.59, PE 0.2, P = .35). The 90-day models were NIHSS = 22.99 - 0.39 * SSS (R(2) = 0.82, PE -0.3, P = .001), and SSS = 56.68 - 2.20 * NIHSS (R(2) = 0.80, PE -0.4, P = .08). Adjustment did not materially improve the R(2) values.
CONCLUSION: Total scores for NIHSS and SSS may be interconverted with good precision; the mathematic conversion equations may prove useful in clinical practice and in comparison of data from observational studies and randomized trials.

Entities:  

Mesh:

Year:  2009        PMID: 19900650     DOI: 10.1016/j.jstrokecerebrovasdis.2009.02.003

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  26 in total

Review 1.  Heart rate variability as a biomarker of functional outcomes in persons with acquired brain injury: Systematic review and meta-analysis.

Authors:  Yejin Lee; Ryan J Walsh; Mandy W M Fong; Marek Sykora; Michelle M Doering; Alex W K Wong
Journal:  Neurosci Biobehav Rev       Date:  2021-10-06       Impact factor: 8.989

Review 2.  Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke.

Authors:  Philip Mw Bath; Kailash Krishnan; Jason P Appleton
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

3.  Elevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers.

Authors:  Simona Lattanzi; Mauro Silvestrini; Leandro Provinciali
Journal:  Int J Hypertens       Date:  2013-01-31       Impact factor: 2.420

4.  Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.

Authors:  Pitchaiah Mandava; Santosh B Murthy; Neel Shah; Yves Samson; Marek Kimmel; Thomas A Kent
Journal:  Neurology       Date:  2019-03-20       Impact factor: 11.800

5.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2014-10-21       Impact factor: 79.321

6.  Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke.

Authors:  Håkan Lövkvist; Ann-Cathrin Jönsson; Holger Luthman; Katarina Jood; Christina Jern; Tadeusz Wieloch; Arne Lindgren
Journal:  BMC Neurol       Date:  2014-09-28       Impact factor: 2.474

7.  Genetic variation at the BDNF locus: evidence for association with long-term outcome after ischemic stroke.

Authors:  Tara M Stanne; Anna Tjärnlund-Wolf; Sandra Olsson; Katarina Jood; Christian Blomstrand; Christina Jern
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  Insulin-Like Growth Factor-II and Ischemic Stroke-A Prospective Observational Study.

Authors:  Daniel Åberg; N David Åberg; Katarina Jood; Petra Redfors; Christian Blomstrand; Jörgen Isgaard; Christina Jern; Johan Svensson
Journal:  Life (Basel)       Date:  2021-05-29

9.  Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.

Authors:  William N Whiteley; Harold P Adams; Philip M W Bath; Eivind Berge; Per Morten Sandset; Martin Dennis; Gordon D Murray; Ka-Sing Lawrence Wong; Peter A G Sandercock
Journal:  Lancet Neurol       Date:  2013-05-02       Impact factor: 44.182

10.  Prediction and prognostication of neurological deterioration in patients with acute ICH: a hospital-based cohort study.

Authors:  Christian Ovesen; Anders Fogh Christensen; Inger Havsteen; Christine Krarup Hansen; Sverre Rosenbaum; Engin Kurt; Hanne Christensen
Journal:  BMJ Open       Date:  2015-07-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.